We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors

Sanjay Ahuja, MD

Specialty: Pediatric Hematology and Oncology

Sanjay Ahuja, MD
  • Director, Hemophilia Program, UH Cleveland Medical Center
  • Medical Director, Pediatric Hematology/Oncology, UH Rainbow Babies and Children's Hospital
  • Medical Director, Pediatric Hematology/Oncology, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine

Contact

216-844-3345

Biography

Expertise

  • Bleeding Disorders
  • Pediatric Hematology
  • Pediatric Hemostasis
  • Thrombocytopenias
  • Thrombotic Disorders

Videos

Watch to find out more about this University Hospitals provider.

Certifications & Memberships

  • Pediatric Hematology-Oncology - American Board of Pediatrics

Education

Other Education
University Of Pittsburgh School Of Medicine (2002 - 2004)

Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - Children's Hospital Of Pittsburgh Of Upmc (2001 - 2004)

Residency | Pediatrics
Pediatrics - Lincoln Medical And Mental Health Center (1999 - 2001)

Internship | Pediatrics
Pediatrics - Lincoln Medical And Mental Health Center (1998 - 1999)

Medical Education
Seth Gs Medical College, Maharashtra University Of Health Sciences (1993)

Languages Spoken

English, Hindi

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Sanjay Ahuja disclosed the following Outside Relationships with Industry:

  • - Baxalta - Honoraria
  • - Biogen Idec - Honoraria
  • - Dynavax Technologies - Ownership
  • - Adaptimmune Therapeutics - Ownership